Diabetes Technology Society

Diabetes Technology Society (DTS) is a nonprofit organization that promotes the use of new technology to assist patients living with diabetes.

It was established in 2001 by David C. Klonoff (Mills Peninsula Health Services).

DTS is responsible for organizing three scientific conferences each year. They are:

• Diabetes Technology Meeting
• Clinical Diabetes Technology Meeting
• European Clinical Diabetes Technology Meeting^[1]

Some of the educational objectives discussed during these conferences include:

• The understanding of cybersecurity and its relation to the medical device industry, specifically diabetes devices
• Go over the new technology being implemented to help in the release of the Artificial pancreas into the market
• Discuss Continuous glucose monitor and their benefits in comparison to self-monitoring of blood glucose
• Identify new insulin products (like Inhaled insulin, biosimilar insulin, glucose responsive insulin). Also, discuss how global warming has an effect on insulin stability
• Go over insulin pump therapy
• Discuss social media and its effects on benefiting managing diabetes
• Successfully understand how mobile apps could benefit managing diabetes
• Identify the new treatments available in the market for "Diabetic foot" and go over future treatments for diabetic limb salvage and prevention^[2][3]

In 2013, DTS gained support from the Food and Drug Administration for a proposed post-market surveillance system to test the accuracy and quality of self-monitoring of blood glucose systems.^[4] In 2014, they launched the surveillance program.^[5][6]

The bi-monthly peer-reviewed medical journal, Journal of Diabetes Science and Technology, is published by SAGE Publications on behalf of Diabetes Technology Society.

This article about a United States health organization is a stub. You can help Wikipedia by expanding it.

• v
• t
• e